Page URL: https://www.bionews.org.uk/page_137161

HFEA to issue regulations on IVF add-ons

16 July 2018
Appeared in BioNews 958

The Human Fertilisation and Embryology Authority (HFEA) will require fertility clinics to give patients full information about any IVF 'add-on' services being offered to them.

This new rule will ensure that patients seeking fertility treatment are fully informed before undertaking any extra procedures that have not been proven effective.

'Clinics tell us it's due to patient pressure,' said Sally Cheshire, chair of the HFEA. 'We're saying clinics need to be robust and ethical in what they offer, particularly if they're asking patients to pay for those treatments.'

'Add-ons' are optional procedures which aim to increase the chances of a successful pregnancy resulting from fertility treatment. Currently, 70 percent of fertility clinics in London offer add-ons, and the price for a single procedure can range from £400-£1000, according to Tech Times. However, the most commonly offered add-on treatments have either never been tested in clinical trials, or have not been tested thoroughly enough to demonstrate efficacy, according to the HFEA

Add-ons such as 'assisted hatching', which uses a laser, acid or other means to break through an embryo's protein coating to assist implantation, or 'time-lapse imaging', which tracks the development of embryos under a microscope, have not been proven to increase live birth rates. Similarly, 'reproductive immunology', which uses drugs to suppress the mother's immune system, not only lacks evidence demonstrating efficacy, but has been shown to be associated with harmful side-effects such as chronic infections, blood poisoning and severe allergic reactions. 

Two common add-ons, endometrial scratching and the 'Augment' treatment which injects more of the mother's own mitochondria into her eggs, have recently been shown to have no effect in clinical trials (see BioNews 957 here and here).

'There isn't anything particularly different as far as we're concerned,' said Cheshire. 'There's no effective evidence that these treatments work, and some of them may even be potentially harmful for some patients, which clearly isn't ethical.'

This new rule for add-ons is set to come into effect in October according to The Guardian, pending approval from the Health Secretary.

SOURCES & REFERENCES
New IVF Regulation Protects Patients From Expensive And Potentially Dangerous Fertility Add-Ons
Tech Times |  9 July 2018
UK fertility regulator to issue new rules on expensive IVF add-ons
The Guardian |  9 July 2018
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
19 November 2018 - by Rikita Patel 
The Human Fertilisation Embryology Authority has signed a consensus statement calling for private IVF clinics to stop charging patients costly optional add-on treatments that are not proven to work...
3 July 2018 - by Shaoni Bhattacharya 
A controversial technique to super-charge patients' eggs with their own mitochondria before undergoing assisted reproduction does not improve success rates, suggests a new study...
3 July 2018 - by Shaoni Bhattacharya 
A common procedure, known as endometrial or womb 'scratching', as an add-on to IVF has been shown to have no effect on pregnancy or birth rates...
8 May 2017 - by Shaoni Bhattacharya 
The UK's fertility regulator, the HFEA, says it will be investigating a series of allegations concerning the fertility industry made by the Daily Mail newspaper last week...
3 April 2017 - by Antony Blackburn-Starza 
The controversial issue of IVF 'add-ons' – techniques and treatments offered to fertility patients on top of standard IVF – has been the subject of intense debate and media attention since last November's BBC Panorama's documentary, which claimed that many techniques advertised on fertility clinics websites were not backed up by good scientific evidence of success...
5 December 2016 - by Lucas Taylor 
There is a lack of quality evidence on the benefits of almost all fertility clinic add-on treatments, a study published in the BMJ has suggested...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.